Results 81 to 90 of about 34,105 (239)

SUBDUE‐3: SUB‐urothelial DUrvalumab‐89zirconium injEction; a phase 0 biodistribution study protocol

BJU International, EarlyView.
Kevin G. Keane, Richard Gauci, Roslyn J. Francis, Andrew M. Scott, Cynthia Hawks, Andrisha‐Jade Inderjeeth, Ian D. Davis, Jayne Lim, Andrew Redfern, Dickon Hayne   +9 more
wiley   +1 more source

The effect of birth weight and gestational age on BCG-induced immune responses in infants following BCG vaccination

, 2010
Includes bibliographical references (leaves 102-114).Bacillus Calmette?Gu?rin (BCG), the only currently licensed tuberculosis (TB) vaccine, provides variable efficacy. Despite the use of BCG, TB remains a global health problem.
Dube, Frederick
core  

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. [PDF]

, 2008
Willem Hanekom and colleagues make recommendations on assay harmonization for novel tuberculosis vaccine ...
Weichold Frank F, Willem A Hanekom, Uli J Fruth, T Mark Doherty, Hoft, DF, Ottenhoff, Tom H. M., Hanekom Willem A, Doherty, T Mark, Hoft Dan F, Doherty, TM, Dan F Hoft, Shreemanta K Parida, Fruth, Uli J., Weichold, Frank F., Hoft, Dan F., Dockrell Hazel M, Helen Fletcher, Fruth Uli J, Hanekom, Willem A., Hazel M Dockrell, McShane Helen, Ottenhoff, TH, Weichold, Frank F, Parida, Shreemanta K., Fletcher, H, Frank F Weichold, Hoft, Dan F, Ottenhoff, Tom HM, Tom H M Ottenhoff, Helen McShane, Hanekom, Willem A, Weichold, FF, Dockrell, Hazel M., Hanekom, WA, Fletcher Helen, Doherty, T. Mark, Parida Shreemanta K, Fruth, Uli J, Doherty T. Mark, Parida, Shreemanta K, Fruth, UJ, Parida, SK, Dockrell, HM, Mcshane, H, Dockrell, Hazel M, Fletcher, Helen, Ottenhoff Tom H. M, McShane, Helen   +47 more
core   +1 more source

Vacina BCG contra tuberculose: efeito protetor e políticas de vacinação BCG vaccine against tuberculosis: its protective effect and vaccination policies

Revista de Saúde Pública, 2007
OBJETIVO: A vacina BCG é utilizada desde 1921, embora ainda apresente controvérsias e aspectos não esclarecidos. O objetivo do artigo foi analisar aspectos relacionados ao efeito protetor da primeira e segunda doses da vacina BCG e as políticas de ...
Susan M Pereira, Odimariles Maria Souza Dantas, Ricardo Ximenes, Mauricio L Barreto   +3 more
doaj   +1 more source

Domestic and International Health Expenditure and Health and Healthcare Use: Evidence From Mozambique

Health Economics, Volume 35, Issue 7, Page 1088-1103, July 2026.
ABSTRACT Evidence on the relationship between public health expenditure and health is mixed and particularly scarce for low‐income countries. Existing studies overlook the subnational distribution of expenditure and rarely distinguish between sources and governance over funding.
Eliana Chavarría‐Pino, Laura Anselmi, Matt Sutton, Sérgio Chicumbe   +3 more
wiley   +1 more source

Evaluation of first generation vaccines against human leishmaniasis and the implication of Leishmanin Skin Test (LST) response in disease prevalence [PDF]

, 2011
This study reports the detailed analysis of the data from ten different clinical trials of first generation prophylactic vaccines (FGV) against leishmaniasis.
Noazin, Sassan
core   +1 more source

Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur

BMC Microbiology, 2011
Background Bacille Calmette-Guerin (BCG) is currently the only available vaccine against tuberculosis (TB) and comprises a heterogeneous family of sub-strains with genotypic and phenotypic differences. The World Health Organization (WHO) affirms that the
Degrave Wim M, Castello-Branco Luiz RR, da Silva Renata F, Pereira Melissa P, Gomes Leonardo HF, Correa Paloma R, Kalume Dario E, Berrêdo-Pinho Marcia, Mendonça-Lima Leila   +8 more
doaj   +1 more source

BCG Vaccination and Tuberculosis in Japan.

Journal of Epidemiology, 2003
This paper summarizes Bacillus Calmette-Guerin (BCG) vaccination and revaccination policies in Japan, its cost-effectiveness, side effects, proposed selective vaccination strategy, and present tuberculosis situation in Japanese perspectives based on Medline database and other published reports.
Rahman, Mahbubur, Takahashi, Osamu, Goto, Masashi, Fukui, Tsuguya   +3 more
openaire   +3 more sources

Respiratory Organ‐on‐a‐Chip for Disease Modeling: From Architecture to Functional Integration

Advanced Healthcare Materials, Volume 15, Issue 23, 19 June 2026.
Respiratory organ‐on‐a‐chip (ROC) models capture key mechanical and cellular cues of the human respiratory system, enabling quantitative dissection of disease mechanisms. This review links ROC architectures to disease modeling, functional integration, and commercialization, and proposes a decision framework that aligns model complexity with mechanistic
Jinzhuo Hu, Yongjie Tang, Sidi Liu, Tao Xu, Qian Liu   +4 more
wiley   +1 more source

The whole genome sequence of Polish vaccine strain Mycobacterium bovis BCG Moreau

Microbiology Spectrum
Currently, tuberculosis immunoprophylaxis is based solely on Bacillus Calmette-Guérin (BCG) vaccination, and some of the new potential tuberculosis vaccines are based on the BCG genome. Therefore, it is reasonable to analyze the genomes of individual BCG
Katarzyna Krysztopa-Grzybowska, Jakub Lach, Maciej Polak, Dominik Strapagiel, Jaroslaw Dziadek, Marcin Olszewski, Aleksandra A. Zasada, Aniela Darlińska, Anna Lutyńska, Ewa Augustynowicz-Kopeć   +9 more
doaj   +1 more source